Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdul-Razak HH"'
Autor:
Abdul-Razak HH; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK., Rocca CJ; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK., Howe SJ; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.; Gene Transfer Technology Group, UCL Institute for Women's Health, University College London, London, UK., Alonso-Ferrero ME; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK., Wang J; Sangamo Therapeutics, Inc., Richmond, California, USA., Gabriel R; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany., Bartholomae CC; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany., Gan CHV; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK., Garín MI; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)/Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Roberts A; Department of Medical and Molecular Genetics, King's College London, London, UK., Blundell MP; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK., Prakash V; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK., Molina-Estevez FJ; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK.; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)/Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Pantoglou J; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK., Guenechea G; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)/Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Holmes MC; Sangamo Therapeutics, Inc., Richmond, California, USA., Gregory PD; Sangamo Therapeutics, Inc., Richmond, California, USA., Kinnon C; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK., von Kalle C; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany., Schmidt M; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany., Bueren JA; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)/Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Thrasher AJ; Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.; Great Ormond Street Hospital NHS Foundation Trust, London, UK., Yáñez-Muñoz RJ; AGCTlab.org, Centre for Gene and Cell Therapy, Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, UK. rafael.yanez@royalholloway.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2018 May 29; Vol. 8 (1), pp. 8214. Date of Electronic Publication: 2018 May 29.
Autor:
Rocca CJ; School of Biological Sciences, Royal Holloway-University of London, Egham, Surrey, UK., Abdul-Razak HH, Holmes MC, Gregory PD, Yáñez-Muñoz RJ
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2014; Vol. 1114, pp. 325-38.
Autor:
Semerdjieva S; Centre of Biomedical Sciences, School of Biological Sciences, Royal Holloway University London, Surrey, United Kingdom., Abdul-Razak HH, Salim SS, Yáñez-Muñoz RJ, Chen PE, Tarabykin V, Alifragis P
Publikováno v:
Molecular and cellular biology [Mol Cell Biol] 2013 Apr; Vol. 33 (7), pp. 1442-55. Date of Electronic Publication: 2013 Feb 04.